XOMA (XOMAO) Stock Price, News & Analysis

Company Overview

XOMA Royalty Corporation is a biotechnology royalty aggregator. The company acquires and manages rights to potential royalties, milestone payments and other economic benefits from drug candidates and marketed medicines developed by biotechnology and pharmaceutical partners.

Rather than focusing on developing and commercializing its own medicines, XOMA builds a portfolio of interests in partnered assets across therapeutic areas and stages of development. Its returns depend on the progress and commercial performance of those products and candidates.

The company traces its roots to XOMA, a biotechnology business with a history of developing antibody-based therapies. It later shifted its focus toward managing royalty interests and adopted the XOMA Royalty name. Its portfolio is tied to products and development programs pursued by partners in markets around the world.

Key Stats

• Today's Range: $25.00 to $25.00
• 50-Day Range: $25.00 to $25.00
• 52-Week Range: $24.86 to $26.40
• Volume: N/A
• Average Volume: 4,279 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 8.36%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:XOMAO
• CIK: 791908
• Web: www.xoma.com
• Phone: 510-204-7200
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $7.65 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A